Upon entering the human host, the ability of Bordetella pertussis to attach to and infect the epithelium of the upper respiratory tract is an essential first step in the pathogenesis of the disease pertussis. Bacterial surface lectins, which are typically located on fimbriae, have been shown in many systems to be critical for the initiation of infection by mediating bacterial adherence to epithelial cells (14) through lectincarbohydrate interactions, which play an important role in many biological systems (42). While the nature of the B. pertussis fimbrial receptor is not clear, filamentous hemagglutinin (FHA), a large filamentous protein that is both surface associated and secreted from virulent bacteria, has been shown to have lectin-like activity, as demonstrated by its sugarinhibitable agglutination of erythrocytes (33). The structural gene of FHA has been cloned and sequenced (8, 9), and the role of FHA as a crucial mediator of Bordetella-host cell interactions has been well documented (18, 37, 47, 48) .
respiratory pathogen Bordetella pertussis. A number of binding mechanisms have been described for the interaction of FHA with eukaryotic cells. We have focused on its function as a sulfated polysaccharide-binding protein and on identifying potential receptors for FHA on the epithelial cell surface. Using a thin-layer overlay technique, we found that FHA binds specifically to sulfated glycolipids but not to gangliosides or other neutral glycolipids. These results suggest that epithelial cell surface sulfated glycolipids function as receptors for FHA. Further studies demonstrated that a Chinese hamster ovary (CHO) cell strain deficient in glycosaminoglycan expression exhibits greatly diminished attachment to FHA. By FHA-Affi-Gel chromatography, a putative receptor for FHA that has characteristics consistent with a heparan sulfate proteoglycan was isolated from epithelial cell extracts. In addition, by using recombinant FHA fusion proteins, a specific glycosaminoglycanbinding domain located near the N terminus of the FHA molecule was identified. Our results indicate that the B. pertussis adhesin FHA may utilize sulfated glycolipids and proteoglycans commonly found on the surface of human cells and tissues to initiate infection.
Upon entering the human host, the ability of Bordetella pertussis to attach to and infect the epithelium of the upper respiratory tract is an essential first step in the pathogenesis of the disease pertussis. Bacterial surface lectins, which are typically located on fimbriae, have been shown in many systems to be critical for the initiation of infection by mediating bacterial adherence to epithelial cells (14) through lectincarbohydrate interactions, which play an important role in many biological systems (42) . While the nature of the B. pertussis fimbrial receptor is not clear, filamentous hemagglutinin (FHA), a large filamentous protein that is both surface associated and secreted from virulent bacteria, has been shown to have lectin-like activity, as demonstrated by its sugarinhibitable agglutination of erythrocytes (33) . The structural gene of FHA has been cloned and sequenced (8, 9) , and the role of FHA as a crucial mediator of Bordetella-host cell interactions has been well documented (18, 37, 47, 48) .
FHA has been shown to promote attachment to a variety of eukaryotic cell types and tissues and appears to interact with complementary eukaryotic receptors through a number of different binding mechanisms. It contains an arginine-glycineaspartic acid (RGD) sequence (38) which mediates its attachment to macrophages by interacting with the CR3 integrin receptor (37) . In addition, previous work has described the interaction of B. pertussis with ciliated cells in a manner that can be inhibited by the saccharide galactose, and FHA has been shown to bind to lactose-containing glycolipids (46) . Menozzi et al. (33) have shown that this adhesin binds to the highly sulfated polysaccharide heparin and that FHA-mediated agglutination of erythrocytes can be inhibited by sulfated sugars. Brennan et al. (5) have previously demonstrated that virulent B. pertussis organisms bind specifically to galactosylceramide-sulfate, or sulfatide. In addition, it was shown that sulfated sugars can partially inhibit the adherence of B. pertussis to WiDr cells, a cell line known to express large quantities of sulfatide molecules (20) . Also, dextran sulfate, a high-molecular-weight (MW) glucose polymer containing sulfate, but not dextran or galactose, was demonstrated to significantly decrease the attachment of B. pertussis to hamster trachea cells. Subsequently, we have found that this adhesion mechanism is at least in part mediated by the heparin-binding activity of FHA (34) .
In this paper, we describe the binding of FHA to the epithelial cell surface molecule heparan sulfate glycosaminoglycan, a polysaccharide which is structurally similar to heparin in that they both are based on the disaccharide unit glucuronic acid-n-acetylglucosamine that has undergone sulfation modifications and epimerizations of glucuronic acid to iduronic acid (10) . In general, heparan sulfate glycosaminoglycans contain fewer sulfate groups and fewer iduronic acid units than does heparin (16 
glucopyranoside (n-octylglucoside) detergent was purchased from Boehringer Mannheim (Indianapolis, Ind.). The glycolipids galactosylceramide, glucosylceramide, ganglioside GM1, asialo GM1, and sulfatide were purchased from Sigma. Plasmid pRIT13202 has been described previously (8) , the construction of pMAL2 and pMAL&3 is described elsewhere (34) , and pMAL-c and Escherichia coli TG1 were purchased from New England Biolabs (Beverly, Mass.). This expression system was used as recommended by the supplier. E. coli TG1 containing recombinant pMAL-c derivatives were grown in Luria-Bertani medium containing 100 ,ug of ampicillin per ml (41) .
Antibodies. Polyclonal anti-F-A antibodies were generated by immunizing rats with 50 ,ug of FHA purified by heparinSepharose chromatography as described by Menozzi et al. (33) . After 3 weeks, two booster doses of 50 pug of purified FHA were given at 3-week intervals. Ten days after the second booster dose, serum was obtained, and nonspecific antibodies were absorbed twice with extracts prepared from B. pertussis BPGR4, a strain lacking the FHA structural gene (28) . The antipertactin monoclonal antibody (MAb) E4D7 was a gift from Iver Heron, Statens Seruminstitut, Copenhagen, Denmark. The anti-FHA MAbs X3C and X4B have been described previously (24) , as has BPE3, which reacts with pertactin (6).
Electron microscopy. B. pernussis 18323 was incubated with HeLa cell monolayers and immunogold labeled by using the anti-FHA immunoglobulin M MAb X4B (5-nm gold particles) and the anti-pertactin immunoglobulin G MAb E4D7 (15-nm gold particles) as previously described (23) . The samples were embedded and stained as described previously (6) [35S]sodium sulfate (30 jxCi/ml) was then added to the cells in the sulfate-free medium, and the mixture was incubated for 24 h. Cells were also labeled for 24 h in medium without fetal calf serum which contained 10 ,Ci of D-[6-3H]glucosamine hydrochloride per ml and 1 mM glucose.
FHA-Affi-Gel chromatography. The FHA-Affi-Gel column was made as follows: 3 mg of FHA (1.5 ml) was dialyzed for 2 h against 1 liter of 0.1 M NaHCO3 (pH 8.0) with 0.3 M NaCl and 1 mM protease inhibitor AEBSF (coupling buffer). AffiGel 10 (Bio-Rad) gel slurry (1.5 ml) was washed in cold water followed by coupling buffer. The gel slurry was mixed with FHA overnight at 4°C in the presence of 100 ,ug of dextran sulfate (MW, 500,000) per ml in order to protect potential sulfated polysaccharide sites on FHA from coupling to the resin. After blocking with an equal volume of 1 M ethanolamine (pH 8.0) for 1 h at room temperature, the column was thoroughly washed with coupling buffer followed by n-octylglucoside buffer (0.025 M Tris-HCl [pH 6.9] with 0.15 M NaCl, 1 mM MnCl 50 mM n-octylglucoside, and 1 mM AEBSF). Two 150-cm tissue culture flasks containing 80 to 90% confluent [35S]sodium sulfate, [3H]glucosamine, or unlabeled HeLa or CHO cells were scraped off, washed three times in DPBS, and resuspended in 1 ml of ice-cold DPBS plus 1 ml of ice-cold n-octylglucoside buffer containing 200 mM n-octylglucoside. After mixing at 4°C for 30 min, the material was clarified by centrifugation at 17,000 x g for 30 min. The supernatant was added to the FHA-Affi-Gel column and incubated in a rotating mixer at 4°C for 4 h or overnight. After washing with 20 column volumes of n-octylglucoside buffer, the column was eluted with 500 jig of dextran (MW, 500,000) per ml followed by 500 ,ug of either heparin or dextran sulfate (MW, 500,000) per ml. In other experiments, the column was eluted with a stepwise NaCl gradient, from 0.25 M to 2 M NaCl in n-octylglucoside buffer. Fractions were analyzed by SDSpolyacrylamide gel electrophoresis (PAGE), followed by toluidine blue staining or autoradiography.
Enzymatic digestion of glycosaminoglycans. Glycosaminoglycan material eluted off the FHA-Affi-Gel column with a sulfated polysaccharide was exposed to either glycosidase chondroitin ABC lyase or heparitinase essentially as described by Yamagata et al. (51) . Briefly, the chondroitin ABC lyase digestion was performed as follows: acetone-precipitated eluate was resuspended in 10 plI of 0.4 M Tris (pH 8.0) plus 10 6 h at 37°C, acetone precipitated, and analyzed by SDS-PAGE and toluidine blue staining (40) .
Production and purification of recombinant FHA fragments fused to the E. coli maltose-binding protein. Various recombinant FHA fragments were produced in E. coli TG1 as polypeptides fused to the E. coli maltose-binding protein (MalE) by using pMAL-c (15) . The construction of pMAL2 and pMAL83 has been previously described (34) . To construct the pMAL85 plasmid, the 1,360-bp BamHI-PstI fragment encoding the C-terminal region of the mature FHA was isolated from pRIT13202 and inserted in the correct reading frame into pMAL-c previously digested with the same restriction enzymes. The pMAL80 plasmid was constructed as follows: the self-complementary oligonucleotide 5 and survive inside epithelial cells in vitro (13, 23) . Electron microscopic examination (Fig. 1) raphy (Fig. 2B) . A replica chromatogram was also probed with pertactin, another adhesin of B. pertussis which mediates attachment and entry into epithelial cells (23, 25) . No binding to sulfatide or the other glycolipids could be detected with pertactin-coated latex beads (Fig. 2C) . These results indicate that FHA can bind to sulfated glycolipids and imply that sulfatide may function as a specific receptor for FHA.
A CHO cell glycosaminoglycan-deficient strain exhibits diminished attachment to FHA. Earlier studies have demonstrated that human epithelial cell lines, including CHO and HeLa cells, attach to FHA coated on plastic wells and this interaction can be specifically inhibited by sulfated sugars (23, 34) . The finding that FHA can bind to sulfated glycolipids on thin-layer chromatograms prompted us to search for cell surface proteins containing sulfated sugars which might also serve as receptors for FHA. We utilized CHO cell variants which are deficient in the expression of glycosaminoglycans to examine the possibility that FH-A interacts with cell surface proteoglycans, macromolecules composed of one or more glycosaminoglycan chains attached to a core protein. A [3H]thymidine-labeled CHO mutant, pgsA 745, deficient in the synthesis of both heparan sulfate and chondroitin sulfate glycosaminoglycans (11), and radiolabeled CHO Ki parent cells were incubated in plastic wells coated with FHA and washed after either 90 or 120 min. As seen in Fig. 3 , the CHO pgsA 745 mutant exhibited a 78% decrease in attachment to FHA compared with the parent CHO cells after 90 min and a more than 50% decrease after 120 min. Likewise, another CHO cell mutant, pgsB 761 (12) , which also is blocked in its expression of heparan sulfate and chondroitin sulfate, shows a similar decrease in attachment (data not shown). These results implicate cell surface proteoglycans as receptors for FHA.
A high-MW sulfated glycoconjugate binds to FIA. In order to determine whether sulfated epithelial cell glycoconjugates bind to FHA, CHO Kl cells were harvested and extracted in buffer containing n-octylglucoside detergent. The extracted cell lysate material (Fig. 4, lane 1) was incubated with an FHA-Affi-Gel resin and then subjected to a stepwise 0.3 to 1 M NaCl gradient. Samples were subjected to SDS-PAGE and incubated with toluidine blue, a stain that allows visualization of anionic polysaccharides. Although the NaCl gradient re- moves little material from the column (lanes 2 to 6), a diffuse high-MW material is specifically eluted from the column with 500 ,ug of dextran sulfate per ml (lane 7). Additional experiments using extracts from both CHO and HeLa epithelial cell lines demonstrate that little of the bound material is removed from the column even with 2 M NaCl, indicating that this high-MW glycosylated material binds avidly to FHA. In contrast, when FHA is applied to a heparin or dextran sulfate column, the FHA can be eluted with a relatively low-ionicstrength salt concentration of 300 mM NaCl (33, 34) .
In order to further define the epithelial cell components which interact with FHA, HeLa cells were metabolically labeled with [35S]sodium sulfate or [3H]glucosamine, harvested, and extracted in the n-octylglucoside buffer. The extracted radiolabeled cell lysate material (Fig. 5, lane 1) was incubated with the FHA-Affi-Gel resin and then eluted with dextran followed by the sulfated polysaccharide heparin. SDS-PAGE of the eluted fractions followed by autoradiography indicates that dextran did not remove any radiolabeled material from the column (Fig. 5, lane 3) ; however, the heparin eluate is composed of diffuse high-MW material, similar to that stained with toluidine blue, which is strongly labeled with sulfate (Fig. 5, lane 4) . In a parallel experiment, [3H] glucosamine also labeled this heparin-eluted material (Fig. 5, (12) . Therefore, to determine if the high-MW sulfated glycoconjugate which binds to FHA is composed of chondroitin sulfate and/or heparan sulfate glycosaminoglycan, unlabeled CHO cell extracts were mixed with the FHA-Affi-Gel column and eluted with dextran sulfate. The eluate was then incubated with either chondroitin ABC lyase or heparitinase. Figure 6 (lane 1) shows that after separation by SDS-PAGE, the eluted material stains strongly with toluidine blue and turns pink (color not visible in photograph), confirming that the material is an anionic polysaccharide (40 purification of the recombinant proteins by affinity chromatography on amylose resin. The DNA fragments that were expressed in this system are depicted in Fig. 7 , and the details of their construction and purification are found in Materials and Methods. During purification, the recombinant E. coli TG1 strains were harvested and analyzed by SDS-PAGE and Western blotting using polyclonal and monoclonal anti-FHA antibodies. All four clones produced recombinant fusion proteins of the expected size and are recognized by anti-FHA antibodies (data not shown).
After purification, the four FHA-hybrid proteins and MalE were applied to a heparin-Sepharose column, washed, and eluted with a high salt concentration. The quantities of protein in the flowthrough and in the eluted fractions were compared with that present in the protein sample prior to chromatography. The results shown in Fig. 8 indicate that more than 90% of the recombinant fusion proteins Mal-2, Mal-83, Mal-85, and, as expected, MalE, were recovered in the flowthrough. However, the protein encoded by pMAL80 was found to be almost completely retained by heparin-Sepharose and eluted with 0.5 M NaCl, a condition similar to that used for the elution of full-length B. pertussis-produced FHA. Control experiments demonstrated that, like FHA, none of the FHAhybrid proteins bound to immobilized dextran (data not shown and see reference 34) .
These studies indicate that the binding of FHA to heparin is not caused by nonspecific electrostatic interactions of any basic amino acid residue with heparin but that a specific heparinbinding domain is located in the N-terminal domain of the FHA molecule, most likely between amino acid residues 442 and 863. These results are consistent with our previous findings (34) indicating that the heparin-binding domain of FHA is distinct from the previously identified carbohydrate-binding domain (36) and the RGD-containing domain (38) .
DISCUSSION
Previous work has described the involvement of the RGD sequence in FHA in the binding to the CR3 integrin receptor on macrophages (37) and the interaction of FHA with lactosecontaining glycolipids (46) . Our studies have indicated that the RGD sequence of FHA does not play a role in the attachment of epithelial cells to FHA or the entry of B. pertussis into HeLa cells (23) . However, other evidence suggests that temperatureinduced adherence of B. pertussis to CHO cells does require the RGD domain of FHA (1) . In this study, we show that FHA may also promote B. pertussis adhesion to the epithelial cell surface via other mechanisms that involve a lectin-like interaction with a cell surface sulfated glycoconjugate(s). We have previously shown that sulfated polysaccharides can inhibit the attachment of B. pertussis to both tracheal cells and other epithelial cells (5) . Also , it has been demonstrated (33) that FHA binds specifically to the sulfated polysaccharide heparin and that heparin is a potent inhibitor of FHA-mediated hemagglutination. In addition, only sulfated sugars can disrupt the FHA-heparin interaction, and attachment of CHO cells to FHA is inhibited by sulfated polysaccharides (34) . Here (39) .
Proteoglycans are also essential components of the extracellular matrix and the cell surface which participate in many biological activities, such as mechanical support, cell adhesion, cell proliferation, anticoagulation, and binding of growth factors and other ligands (10, 19 In addition to B. pertussis, a growing list of viruses, bacteria, and parasites utilize glycosaminoglycans and proteoglycans as receptors for attachment. Herpes simplex virus initiates the disease process by binding to cell surface heparan sulfate, a step which is followed by other higher-affinity receptor-ligand interactions (29, 50) . Binding to heparan sulfate has also been reported for Streptococcus pyogenes (3), and both chondroitin sulfate and heparan sulfate inhibit the binding of a Streptococcus mutans protein to heart tissue (7) . Also, the heparan sulfate-binding proteins described for Staphylococcus aureus may be general glycosaminoglycan binding proteins since dermatan sulfate and chondroitin sulfate interfere with the binding of heparan sulfate to S. aureus (26) . Zhang and Stephens have provided evidence that Chlamydia trachomatis utilizes heparan sulfate glycosaminoglycans as a molecular bridge between the organism and the host cell receptors (53) . The gastric pathogen Helicobacterpylori has a strong affinity for heparan sulfate, and this binding is not inhibited by other anionic glycosaminoglycans (2) . The parasite Trypanosoma cruzi expresses a 60-kDa surface protein that binds selectively to heparan sulfate and collagen found in the extracellular matrix (35) .
The initiation of B. pertussis infection is triggered when the organisms are inhaled into the upper respiratory tract. Presumably, the first site that the bacteria encounter is the mucus covering the epithelial lining of the respiratory tract. The tracheobronchial mucus glycoproteins possess oligosaccharides that are sulfated (31) . In addition, sulfated glycolipids are present throughout the respiratory tract (20) , and proteoglycans are ubiquitous on the epithelial cell surface and in the extracellular matrix. Attachment to these sulfated glycoconjugates could effectively secure the microorganism to the site where productive infection can be initiated. FHA appears to be the primary B. pertussis adhesin responsible for early events in the infectious cycle. Portions of the FlIA molecule show a strong resemblance to a number of eukaryotic attachment proteins (27, 37) , and this bacterial adhesin appears to have usurped eukaryotic cell adhesion mechanisms for mediating adherence of B. pertussis to mammalian cells. Recently, it has been shown that FHA possesses extended regions of tandem 19-residue repeats that strongly resemble the leucine-rich repeats present in many eukaryotic proteins implicated in intercellular adhesion (30) . In this paper, we demonstrate another example of FHA's ability to mimic eukaryotic adhesion mechanisms: its attachment to specific glycolipids and glycosaminoglycans.
